Clinical trials
Gastroesophageal Reflux trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Unknown status | 10 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chong Kun Dang Pharmaceutical | 9 |
| Seoul National University Hospital | 9 |
| Addpharma Inc. | 5 |
| Yonsei University | 4 |
| AstraZeneca | 3 |
| Daewoong Pharmaceutical Co. LTD. | 3 |
| HK inno.N Corporation | 3 |
| Ahn-Gook Pharmaceuticals Co.,Ltd | 2 |
| Ajou University School of Medicine | 2 |
| Korea United Pharm. Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroesophageal Reflux | 63 |
| Esophagitis, Peptic | 5 |
| Esophageal Diseases | 3 |
| Heartburn | 2 |
| Bronchiectasis | 1 |
| Bronchitis, Chronic | 1 |
| Chronic Cough | 1 |
| Cough | 1 |
| Diabetes Mellitus | 1 |
| Dysbiosis | 1 |
Trials
Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.